MK-458, A SELECTIVE AND POTENT D2 RECEPTOR AGONIST IN ADVANCED PARKINSONS-DISEASE

被引：9

作者：

LIEBERMAN, A ^{[1
]}

CHIN, L ^{[1
]}

BAUMANN, G ^{[1
]}

机构：

[1] NEW YORK INFIRM BEEKMAN DOWNTOWN MED CTR,DEPT SURG,NEW YORK,NY

来源：

CLINICAL NEUROPHARMACOLOGY | 1988年 / 11卷 / 03期

关键词：

D O I：

10.1097/00002826-198806000-00001

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：191 / 200

页数：10

共 11 条

[1] SYNTHESIS OF 4-SUBSTITUTED 2H-NAPHTH[1,2-B]-1,4-OXAZINES, A NEW CLASS OF DOPAMINE AGONISTS [J].

JONES, JH ;

ANDERSON, PS ;

BALDWIN, JJ ;

CLINESCHMIDT, BV ;

MCCLURE, DE ;

LUNDELL, GF ;

RANDALL, WC ;

MARTIN, GE ;

WILLIAMS, M ;

HIRSHFIELD, JM ;

SMITH, G ;

LUMMA, PK .

JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (12) :1607-1613

[2] TREATMENT OF ADVANCED PARKINSON DISEASE WITH PERGOLIDE [J].

LIEBERMAN, A ;

GOLDSTEIN, M ;

LEIBOWITZ, M ;

NEOPHYTIDES, A ;

KUPERSMITH, M ;

PACT, V ;

KLEINBERG, D .

NEUROLOGY, 1981, 31 (06) :675-682

[3] TREATMENT OF PARKINSONS-DISEASE WITH BROMOCRIPTINE [J].

LIEBERMAN, A ;

KUPERSMITH, M ;

ESTEY, E ;

GOLDSTEIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (25) :1400-1404

[4]

LIEBERMAN AN, 1986, CLIN NEUROPHARMACOL, V9, pS9

[5] LISURIDE COMBINED WITH LEVODOPA IN ADVANCED PARKINSON DISEASE [J].

LIEBERMAN, AN ;

GOLDSTEIN, M ;

LEIBOWITZ, M ;

NEOPHYTIDES, A ;

GOPINATHAN, G ;

WALKER, R ;

PACT, V .

NEUROLOGY, 1981, 31 (11) :1466-1469

[6]

MARTIN GE, 1984, J PHARMACOL EXP THER, V230, P569

[7]

MARTIN GE, 1985, J PHARMACOL EXP THER, V233, P395

[8] POTENT DOPAMINE AGONIST ACTIVITY OF A NOVEL ERGOLINE, 6-ETHYL-9-OXAERGOLINE (EOE) [J].

MARTIN, GE ;

WILLIAMS, M ;

CLINESCHMIDT, BV ;

YARBROUGH, GG ;

JONES, JH ;

HAUBRICH, DR .

LIFE SCIENCES, 1982, 30 (21) :1847-1856

[9]

MEUNTER MD, IN PRESS NEUROLOGY

[10] EARLY COMBINATION OF BROMOCRIPTINE AND LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE - A 5-YEAR FOLLOW-UP [J].

RINNE, UK .

NEUROLOGY, 1987, 37 (05) :826-828

← 1 2 →